108 related articles for article (PubMed ID: 30665717)
1. Crystal structure and biochemical study on argininosuccinate lyase from Mycobacterium tuberculosis.
Chen X; Chen J; Zhang W; Wang H; Liu X; Zhou W; Yang H; Rao Z
Biochem Biophys Res Commun; 2019 Feb; 510(1):116-121. PubMed ID: 30665717
[TBL] [Abstract][Full Text] [Related]
2. Structural studies on M. tuberculosis argininosuccinate lyase and its liganded complex: Insights into catalytic mechanism.
Paul A; Mishra A; Surolia A; Vijayan M
IUBMB Life; 2019 May; 71(5):643-652. PubMed ID: 30615268
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of argininosuccinate lyase from M. tuberculosis: significance of a c-terminal cysteine in catalysis and thermal stability.
Mishra A; Surolia A
IUBMB Life; 2017 Nov; 69(11):896-907. PubMed ID: 29044950
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of the argininosuccinate lyase frequently complementing allele Q286R.
Sampaleanu LM; Vallée F; Thompson GD; Howell PL
Biochemistry; 2001 Dec; 40(51):15570-80. PubMed ID: 11747432
[TBL] [Abstract][Full Text] [Related]
5. Structural and kinetic studies on adenylosuccinate lyase from Mycobacterium smegmatis and Mycobacterium tuberculosis provide new insights on the catalytic residues of the enzyme.
Banerjee S; Agrawal MJ; Mishra D; Sharan S; Balaram H; Savithri HS; Murthy MR
FEBS J; 2014 Mar; 281(6):1642-58. PubMed ID: 24479855
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of amino acid residues involved in argininosuccinate lyase activity in duck delta II crystallin.
Chakraborty AR; Davidson A; Howell PL
Biochemistry; 1999 Feb; 38(8):2435-43. PubMed ID: 10029537
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of duck delta 2 crystallin and the structure of an inactive mutant with bound substrate provide insight into the enzymatic mechanism of argininosuccinate lyase.
Sampaleanu LM; Yu B; Howell PL
J Biol Chem; 2002 Feb; 277(6):4166-75. PubMed ID: 11698398
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of duck delta 1 and delta 2 crystallin suggest conformational changes occur during catalysis.
Sampaleanu LM; Vallée F; Slingsby C; Howell PL
Biochemistry; 2001 Mar; 40(9):2732-42. PubMed ID: 11258884
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of an inactive duck delta II crystallin mutant with bound argininosuccinate.
Vallée F; Turner MA; Lindley PL; Howell PL
Biochemistry; 1999 Feb; 38(8):2425-34. PubMed ID: 10029536
[TBL] [Abstract][Full Text] [Related]
10. Cloning, expression, purification, crystallization and preliminary X-ray studies of argininosuccinate lyase (Rv1659) from Mycobacterium tuberculosis.
Paul A; Mishra A; Surolia A; Vijayan M
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1422-4. PubMed ID: 24316845
[TBL] [Abstract][Full Text] [Related]
11. Structural comparison of the enzymatically active and inactive forms of delta crystallin and the role of histidine 91.
Abu-Abed M; Turner MA; Vallée F; Simpson A; Slingsby C; Howell PL
Biochemistry; 1997 Nov; 36(46):14012-22. PubMed ID: 9369472
[TBL] [Abstract][Full Text] [Related]
12. Allosteric regulation of menaquinone (vitamin K
Bashiri G; Nigon LV; Jirgis ENM; Ho NAT; Stanborough T; Dawes SS; Baker EN; Bulloch EMM; Johnston JM
J Biol Chem; 2020 Mar; 295(12):3759-3770. PubMed ID: 32029475
[TBL] [Abstract][Full Text] [Related]
13. Conformational changes upon ligand binding in the essential class II fumarase Rv1098c from Mycobacterium tuberculosis.
Mechaly AE; Haouz A; Miras I; Barilone N; Weber P; Shepard W; Alzari PM; Bellinzoni M
FEBS Lett; 2012 Jun; 586(11):1606-11. PubMed ID: 22561013
[TBL] [Abstract][Full Text] [Related]
14. Human argininosuccinate lyase: a structural basis for intragenic complementation.
Turner MA; Simpson A; McInnes RR; Howell PL
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9063-8. PubMed ID: 9256435
[TBL] [Abstract][Full Text] [Related]
15. Intragenic complementation and the structure and function of argininosuccinate lyase.
Yu B; Howell PL
Cell Mol Life Sci; 2000 Oct; 57(11):1637-51. PubMed ID: 11092456
[TBL] [Abstract][Full Text] [Related]
16. Structural and mechanistic studies on N(2)-(2-carboxyethyl)arginine synthase.
Caines ME; Sorensen JL; Schofield CJ
Biochem Biophys Res Commun; 2009 Aug; 385(4):512-7. PubMed ID: 19477162
[TBL] [Abstract][Full Text] [Related]
17. Structure determination and refinement at 2.44 A resolution of argininosuccinate lyase from Escherichia coli.
Bhaumik P; Koski MK; Bergmann U; Wierenga RK
Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1964-70. PubMed ID: 15502303
[TBL] [Abstract][Full Text] [Related]
18. Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site.
Kasbekar M; Fischer G; Mott BT; Yasgar A; Hyvönen M; Boshoff HI; Abell C; Barry CE; Thomas CJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7503-8. PubMed ID: 27325754
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms for intragenic complementation at the human argininosuccinate lyase locus.
Yu B; Thompson GD; Yip P; Howell PL; Davidson AR
Biochemistry; 2001 Dec; 40(51):15581-90. PubMed ID: 11747433
[TBL] [Abstract][Full Text] [Related]
20. Recovery of argininosuccinate lyase activity in duck delta1 crystallin.
Tsai M; Koo J; Howell PL
Biochemistry; 2005 Jun; 44(25):9034-44. PubMed ID: 15966727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
